Form 8-K AbbVie Inc. For: Dec 31

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

�

�

FORM�8-K

�

CURRENT REPORT

Pursuant to Section�13 or 15(d)�of the

Securities Exchange Act of 1934

�

Date of Report (Date of earliest event reported): December�31, 2014

�

ABBVIE INC.

(Exact name of registrant as specified in its charter)

�

�

�

�

1 North Waukegan Road

North Chicago,�Illinois 60064-6400

(Address of principal executive offices)(Zip Code)

�

Registrant�s telephone number, including area code:� (847) 932-7900

�

Check the appropriate box below if the Form�8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

�

o����������������� Written communications pursuant to Rule�425 under the Securities Act (17 CFR 230.425)

�

o����������������� Soliciting material pursuant to Rule�14a-12 under the Exchange Act (17 CFR 240.14a-12)

�

o����������������� Pre-commencement communications pursuant to Rule�14d-2(b)�under the Exchange Act (17 CFR 240.14d-2(b))

�

o����������������� Pre-commencement communications pursuant to Rule�13e-4(c)�under the Exchange Act (17 CFR 240.13e-4(c))

�

�

�

Item 5.02� Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

�

(e)�� The agreements regarding change in control by and between AbbVie and its named executive officers have been renewed through December�31, 2016 in accordance with the agreement terms. There were no other changes to the agreements. The form of change in control agreement was filed as Exhibit�10.13 of Amendment No.�5 to the Company�s Registration Statement on Form�10 filed on November�16, 2012.

�

2

�

SIGNATURE

�

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

�

�

Date:�December�31, 2014	ABBVIE INC.
�	�
�	By:	/s/ Laura J. Schumacher
�	�	Laura J. Schumacher
�	�	Executive Vice President, Business Development,
�	�	External Affairs and General Counsel

�

3